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Abstract With the rapid development of graphene synthesis
and functionalization approaches, graphene and its related de-
rivatives have shown great potential in many applications in
material science, including biomedical applications. Several
in vitro and in vivo studies clearly showed no definitive risks,
while others have indicated that graphene might become
health hazards. In this study, we explore the biocompatibility
of graphene-related materials with chicken embryo red blood
cells (RBC). The hemolysis assay was employed to evaluate
the in vitro blood compatibility of reduced graphene, graphene
oxide, and reduced graphene oxide, because these materials
have recently been used for biomedical applications, including
injectable graphene-related particles. This study investigated
structural damage, ROS production and hemolysis of chicken
embryo red blood cells. Different forms of graphene, when
incubated with chicken embryo RBC, were harmful to cell
structure and induced hemolysis.
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Introduction
Graphene, a newly discovered allotrope of carbon, is a single,
two-dimensional layer of carbon atoms (Novoselov et al.
2004). Carbon atoms, through hybridization between one σ
orbital and two π orbitals, form trigonal planar structures with
σ bonds between them and π bonds perpendicular to the pla-
nar structure. Since its discovery, graphene has attracted great
attention in the fields of biology and medicine, including areas
such as drug/gene delivery (Feng et al. 2011; Liu et al. 2008
and Wu et al. 2014), cancer therapy (Zhang et al. 2010),
bioimaging (Shen et al. 2012), biosensing (Shen et al. 2012),
antibacterial materials (Hu et al. 2010), and tissue scaffolds
(Nayak et al. 2011). Despite these promising applications, the
potential toxicity of graphene, althoughwidely investigated, is
still unclear. Several studies indicate graphene properties
which might be related to its toxicity, such as surface area
(Mu et al. 2012; Akhavan et al. 2012), number of layers
(Sanchez et al. 2012), lateral dimension (Yue et al. 2012),
surface chemistry (Wang et al. 2013), and purity/method of
production (Park and Ruoff 2009; Du et al. 2013; Ciesielski
and Samori 2013). A study by Chang et al. (2011) has shown
that graphene oxide (GO) had no significant cytotoxic effect
on A549 cells. However, Wang et al. (2013) reported that
modifications of GO, resulting in its surface change, had a
toxic effect on human lung fibroblasts. Recent studies con-
ducted by our team indicate that pristine graphene (GN)
causes both genotoxic and dose-dependent cytotoxic effects
towards the U87 cell line. Genotoxic effects were also caused
by reduced graphene oxide (rGO), but not by GO (Jaworski
et al. 2013; Hinzman et al. 2014). GN is able to induce apo-
ptosis in macrophages (Li et al. 2012), while GO, after intra-
venous administration in mice, caused cell infiltration, inflam-
mation, and other pathological changes (Zhang et al. 2011).
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Most of the drug/gene delivery platforms require intravenous
administration; thus, proper assessment of potential toxic effects
of carriers in such systems is of utmost importance. A study
conducted by Sasidharan et al. (2012) showed that pristine and
functionalized graphene exhibit a very high hemocompatibility,
causing less than 0.2% of hemolysis in RBC in concentrations
up to 75μg/ml. Another study indicated that graphene oxide and
graphene sheets (GS) exhibited dose-dependent hemolysis. The
extension of hemolysis depended on the size of used nanoparti-
cles and on their oxygen content (Liao et al. 2011). However,
due to a very high diversity of graphene family materials, the
knowledge about their interaction with blood cells is still insuf-
ficient. Thus, we report our findings regarding interactions be-
tween red blood cells (RBC) and GN produced by physical
exfoliation and GO and rGO synthetized by chemical processes.
We hypothesized that due to different properties of used
graphene, emerging from different methods of its production,
the toxic effects exerted towards RBCmay differ. Therefore, the
objective of this study was to compare toxic effects of different
forms of graphene on RBC.
Material and methods
Preparation and characterization of graphene platelets
Graphene powders (purity >99.99%) were purchased from the
following providers: GN from SkySpring Nanomaterials
(Houston, TX, USA) and GO and rGO from the Institute of
Electronic Materials Technology (Warsaw, Poland). GN was
produced by liquid-phase exfoliation of graphite, whereas GO
was produced by chemical oxidation of graphite, and rGO by
chemical reduction of GO. GO was prepared by a modified
Hummer’s method from acid-washed graphite platelets: 5 g of
graphite was added to 125 ml of sulfuric acid, and 3.25 g of
potassium nitrate was added before the start of the reaction.
The mixture was stirred with a mechanical stirrer.
Subsequently, the beaker with reagents was kept below 5 °C
in a water/ice bath while 15 g of potassium permanganate was
gradually added. The beaker was taken out of the bath and
kept at 30–35 °C with continuous stirring then left at the room
temperature. In the next step, deionized water was added to
the stirred mixture so that the temperature did not exceed
35 °C. The beaker was put into a water bath at a temperature
of 35 °C and stirred for another 1 h. The constantly stirred
mixture was then heated to 95 °C for 15 min. To stop the
reaction, 280 ml of deionized water and 5 ml of hydrogen
peroxide were added. The mixture was rinsed with hydrogen
chloride solution to remove sulfate ions and then rinsed with
deionized water to remove chloride ions. To prepare the rGO,
a water suspension of 50 mg of graphene oxide was acidified
to pH = 1 and heated to 90 °C. Then 12ml of reducingmixture
(0.01 g of ammonium iodide, 9 g of hydrated sodium
hypophosphite, and 1.21 g of sodium sulfite dissolved in
100 ml of deionized water) was added. A black material
(rGO) immediately precipitated. The product was filtered,
washed with deionized water, and dried.
Shape and size of the graphene nanoplatelets were evalu-
ated using a JEM-2000EX transmission electron microscope
(TEM) at 80 keV (JEOL Ltd., Tokyo, Japan) and FEI
QUANTANA 200 scanning electron microscope (SEM).
The samples for TEM were prepared by placing hydrocolloid
droplets into Formvar-coated copper grids (Agar Scientific,
Stansted, UK). The test was performed in triplicate. Zeta po-
tential wasmeasured inmilli-Qwater by a ZEN3500 Zetasizer
Nano ZS (Malvern Instruments,Malvern, UK). The content of
chemical bonds was identified from Fourier transform infrared
(FTIR) spectra and recorded on a Tensor 27 FTIR spectrom-
eter (Bruker, Billerica, MA, USA), with 32 scans at a resolu-
tion of 2 cm−1 in the frequency range 650–4000 cm−1. FTIR
direct-transmittance spectroscopy (KBr) was used to indicate
the degree to which oxygen groups were removed, and the IR
absorption of water from the air was mostly eliminated.
Graphene samples were measured as a pastille mixed with
KBr and compacted under high pressure (>10× atmospheric
pressure). Each measurement was recorded immediately and
repeated three times.
Prior to application, the carbon nanoparticles were dis-
persed in phosphate buffered saline (PBS) to prepare the fol-
lowing concentrations: 50, 500, and 5000 μg/ml. The solu-
tions were then sonicated for 30 min.
Embryo model
Fertilized eggs (Gallus gallus, n = 15) from Hubbard Flex
Line hens were obtained from a commercial hatchery
(Dembowka, Poland). After 19 days of egg incubation (tem-
perature 37 °C, 70% humidity, turning once per hour), the
embryos were immediately decapitated while blood samples
were collected from the jugular vein. Blood samples were
divided into the following groups: control untreated (0% he-
molysis), positive control treated with 3% hydrogen peroxide
(100% hemolysis), GN 50 μg/ml, GN 500 μg/ml, GN
5000 μg/ml, GO 50 μg/ml, GO 500 μg/ml, GO 5000 μg/ml,
rGO 50 μg/ml, rGO 500 μg/ml, and rGO 5000 μg/ml hydro-
colloids diluted in PBS. The samples were placed in
Vacutainer tubes (BD Inc., Franklin Lakes, NJ, USA) contain-
ing ethylenediaminetetraacetic acid (EDTA), gently mixed on
a rotary shaker, and incubated for 3 h at 37 °C. The incubation
time was based on Kutwin et al. (2014). All measurements
were performed with three replicates.
Blood cell morphology
Blood cell morphologywas investigated using light microscopy,
SEM, and TEM.
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Peripheral blood smears were prepared using 5 μl of whole
blood, air-dried, stained peripherally with May-Grünwald-
Giemsa, and examined at a magnification of ×1.000 (Leica
DM750, Leica Microsystems, Nussloch, Germany).
For the SEM examination, the blood samples were centri-
fuged for 5 min at 1200 rpm (Sorvall ST 16, Termofisher
Scientific, Waltham, USA). The RBC pellet was washed in
PBS (0.01 M, pH 7.2; P4417, Sigma), fixed in 2.5% glutaralde-
hyde (G5882, Sigma) for 1 h, washed twice in PBS, and placed
on aluminum SEM stubs. The SEM stubs were kept in a moist
atmosphere for 1 h, washed in PBS, post-fixed in 1% osmium
tetroxide (75,632, Sigma) for 1 h, rinsed in distilled water, and
dehydrated with progressive alcohol solutions (30–50–70–90–
95%) and finally twice in absolute alcohol. The preparations
were further dehydrated with a critical point-dried (Polaron
CPD 7501, Quorum Technologies, Newhaven, East Sussex,
UK) and covered by a thin layer of gold (JEE-4C, JEOL Ltd.,
Tokyo, Japan). The samples were inspected by SEM at 1 KeV
(FEI Quanta 200, FEI Co., Hillsboro, OR, USA).
For the TEM examination, the blood samples were fixed in
2.5% glutaraldehyde and centrifuged at 1200 rpm. The super-
natant was discarded; RBCs were dispersed in deionized wa-
ter. The samples for TEMwere prepared by placing hydrocol-
loid droplets into Formvar-coated copper grids. The test was
performed in triplicate.
Hemolytic assay
The hemolysis assay was performed with embryo whole
blood. The cells are centrifuged for 10 min at 1200 rpm, and
the absorbance of the supernatant, which includes plasma and
lysed erythrocytes, was measured at 540 nm (Infinite M200,
Tecan, Durham, NC, USA). Percentage of cell lysis was de-
termined as compared to the positive group (100% of hemo-
lysis according to Kutwin et al. (2014).
ROS production
The measurement of reactive oxygen species (ROS) produc-
tion was performed with embryo whole blood. The samples
(untreated control, positive control treated with 3% hydrogen
peroxide, GN 50 μg/ml, GN 500 μg/ml, GN 5000 μg/ml,
GO 50 μg/ml, GO 500 μg/ml, GO 5000 μg/ml, rGO
50 μg/ml, rGO 500 μg/ml, and rGO 5000 μg/ml) were
placed in Vacutainer tubes containing EDTA, gently mixed
on a rotary shaker, and incubated for 3 h at 37 °C. ROS
production was evaluated using DCFDA—Cellular
Reactive Oxygen Species Detection Assay Kit (Abcam,
Cambridge, UK). One hundred microliter of each sample
was transferred to opaque-bottomed 96-well plates, and
100 μl of diluted DCFDA was added to each well and
Fig. 1 Characterization of pristine graphene (a, d), oxidized graphene (b, e), and reduced oxidized graphene (c, f) by transmission electron microscopy
(a, b, c) and scanning electron microscopy (d, e, f)
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incubated for an additional 30 min at 37 °C in the dark. ROS
production was measured by fluorescence spectroscopy with
excitation wavelength at 485 nm and emission wavelength at
535 nm on an enzyme-linked immunosorbent assay reader
(Infinite M200, Tecan, Durham, NC, USA).
Statistical analysis
Statgraphics Centurion software (StatPoint Technologies,
Warrenton, VA, USA) was used for the statistical analysis.
The data were analyzed using multifactorial analysis of
Fig. 2 Room-temperature
Fourier transform infrared spectra
of pristine graphene (a), oxidized
graphene (b), and reduced
oxidized graphene (c)
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variance (ANOVA) followed by Tukey’s multiple range test.
P values <0.05 were considered to be statistically significant.
Results
Characterization of graphene nanoplatelets
The mean Zeta potential for the nanoparticle samples was
−8.52 for GN, −43.2 for GO, and −29.6 for rGO. Figure 1
shows representative TEM and SEM images of the graphene
platelets. Most of the graphene platelets were visible as a
single layer or a few layers. The shape of GN, GO, and rGO
platelets was irregular with jagged edges. Hydrophilic GO
platelets formed a single layer, while hydrophobic GN and
rGO platelets often created agglomerates. The thickness of
the materials used was in the nanoscale range, but the surface
area was not, ranging from 100 nm to 10 μm and forming
agglomerates over 10 μm in diameter. The surface diameter
of the GN ranged from 400 nm to 10 μm. GO platelets ranged
from 100 nm to 2.3 μm. The rGO platelets were smaller,
ranging from 100 nm to 1.5 μm in diameter, but agglomerates
were more than 5 μm in diameter. Figure 2 shows typical
FTIR spectra obtained for the different forms of graphene in
this study. GN had the main peak for C=C bonds at
1572 cm−1. GN also had peaks at 1720–1757 cm−1, due to
C=O stretching vibrations from carbonyl and carboxylic
groups. The most characteristic feature for all GO and rGO
platelets was the broad, intense band at 3430–3444 cm−1,
which can be attributed to the O–H stretching vibrations of
hydroxyl groups in adsorbed water molecules, structural OH
groups, and carboxylic acids. GO and rGO also had peaks at
1239–1261 cm−1 caused by C–O–C stretching vibrations
from epoxy-functional groups (Table 1).
Fig. 3 Red blood cell
morphology by light microscopy.
a Control (without treatment). b
Pristine graphene. c Oxidized
graphene—GO. d Reduced
oxidized graphene—rGO. Black
arrows point to GO agglomerates;
red arrows point to rGO
agglomerates
Table 1 Comparison of the physical characteristics of pristine graphene (GN), oxidized graphene (GO), and reduced oxidized graphene (rGO)
Parameter GN GO rGO
Shape Irregular Irregular, filmlike Irregular
Zeta potential (mV) −8.52 −4.32 −29.6
Size 400 nm–1.5 μm 100 nm–2.3 μm 100 nm–1.5 μm, aggregates >5 μm
Surface chemical bonds C=C, C–O–C, O–H C=C, C–O–C, O–H, C–O C=C, C–O–C, O–H, C–O
Production Exfoliation Modified Hummer’s method Chemical reduction of GO
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Microscopic evaluation of morphological changes
Morphological changes and significant lysis of RBC after GN,
GO, and rGO exposure were observed by light microscopy,
SEM, and TEM. Compared to the normal biconcave shape of
untreated RBC in PBS, RBC treated with GN, GO, and rGO
demonstrated both aberrant morphology and recently lysed
RBCs (Fig. 3). The cell membranes were disintegrated; the
shape of cells was deformed, but cells also lost their bicon-
cavity. The observation also showed the increasing level of
swollen cells as a result of hemolysis. Hemagglutination was
also observed in all treated groups (Figs. 4 and 5). The SEM
and TEM images showed cell membrane degradation and loss
of the typical discoid-shape of cells. Pathological forms of
erythrocytes, such as echinocytes and knizocytes, were ob-
served in all treated groups. Analysis of TEM samples from
all treated groups showed the presence of ghost cells, which
are the result of cell lysis.
Hemolysis
In contrast to the control group, GN, GO, and rGO showed
hemolytic properties. Increased concentrations of GN, GO,
and rGO resulted in increased hemolysis (Fig. 6).
Furthermore, the percentage of hemolysis was the highest
for GN—73% at a concentration of 5000 μg/ml. In GO- and
rGO-treated samples, the highest hemolysis rates were ob-
served at the same concentration—27 and 42%, respectively.
The lack of hemolysis in the control group and an almost
100% hemolysis rate in the positive control group treated with
3% hydrogen peroxide confirmed the accuracy of the assay.
ROS production
GN, GO, and rGO significantly (P < 0.05) increased the ROS
production of RBC compared with the control group.
Increased concentrations of all types of graphene resulted in
increased ROS generation. The highest was observed at a
concentration of 5000 μg/ml (Fig. 7).
Discussion
In our study, we used red blood cells from the chicken embryo
model, which allows not only a quick verification of the
hemocompatibility, but also represents a good and precise
model for the evaluation of toxicity (Rashidi and Sottile
2009). A recent study has shown that both surface chemistry
Fig. 4 Visualization of red blood
cell morphology by scanning
electron microscopy. a Control
(without treatment). b Pristine
graphene. c Oxidized graphene. d
Reduced oxidized graphene.
Black arrows point to knizocyte;
white arrows point to echinocyte.
Scale bar, 10 μm
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and size of graphene platelets play a key role in the toxicity,
distribution, and excretion of graphene; therefore, different
graphene materials may have different influences on the or-
ganism (Yang et al. 2013). In the present experiment, the three
different types of graphene nanoplatelets had adverse effects
on RBC. Incubation with GN, GO, and rGO nanoparticles
altered the RBC morphology and led to hemolysis. The cell
membranes were disintegrated and their shape deformed.
Moreover, cells lost their biconcavity. Although all of the
graphene nanoplatelets exhibited dose-dependent hemolytic
activity towards RBC, there were differences in the extent of
hemolysis between different forms of graphene. GN had the
highest hemolytic activity and GO the lowest. This fact may
be explained by different chemical and physical properties of
the investigated nanoparticles. GO nanoparticles are hydro-
philic, well-dispersed in water, and form stable hydrocolloids.
On the other hand, GN and rGO are hydrophobic, often
creating agglomerates in water, which could then easily ad-
here to cell membranes. Due to the irregular edges of GN and
rGO, this adhesion may result in mechanical disruption of
RBC’s plasma membrane integrity, causing leakage.
However, due to its hydrophilic properties, GO interacts with
cell membranes in a different manner than GN and rGO and is
less potent at damaging plasma membranes, which may ex-
plain its lower hemolysis rate. Additionally, the surface charge
and aggregation state of nanomaterials critically influence
their in vitro cytotoxicity (Arivizo et al. 2010; Asharani et al.
2010; Liu et al. 2009). The surface charge of nanoparticles
plays an especially important role in cell-nanoparticle interac-
tions as cell membranes are charged as well. The charged
surface of GO nanoparticles may allow it to interact with
proteins present in the blood, which may result in hemolysis
of RBCs. Another mechanism causing nanoparticle induced
hemolysis is the generation of ROS (Yu et al. 2011). Oxidative
Fig. 5 Visualization of red blood
cell morphology by transmission
electron microscopy. a, b Control
(without treatment). c, d Pristine
graphene. e, f Oxidized graphene.
g, h Reduced oxidized graphene.
White arrows point to graphene
agglomerates; red arrows point to
ghost cells. Scale bar, 5 μm (a, c,
e, g, h) and 2 μm (b, d, f)
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stress can be involved in the toxic effects of graphene-based
nanomaterials. Assessment of ROS production showed a toxic
influence of GN, GO, and rGO on RBC. The interactions of
the graphene with the RBC can lead to excessive ROS gener-
ation. A disruption of membrane functionality from an inter-
action between graphene platelets and the cell membrane ul-
timately causes damage to the cell due to oxidative stress.
In general, the hemolytic properties of graphene
nanoplatelets are influenced by their size, shape, surface
charge, and chemical groups on the surface (Yu et al.
2011).
Liao et al. (2011) reported, similarly to our study, he-
molytic activity of graphene nanoplatelets towards RBC.
However, in another study, pristine and functionalized
graphene had no effect on hemolytic activity (Strojny
et al. 2015).
Hemocompatibility assays are of crucial importance in
evaluating potential biomedical applications of nanoparticles,
as most of them require intravenous administration resulting
in direct interaction of nanoparticles with RBC and different
immune cells. In agreement with previous studies, we suggest
that the method of production and modification of graphene
plays a key role in its hemocompatibility and should be care-
fully and thoroughly considered before therapeutic
application.
Conclusions
GN, GO, and rGO incubated with chicken embryo RBC
caused damage to the structure of RBC and induced dose-
dependent hemolysis. Treatments with all forms of graphene
led to structural damage of cell membranes and formation of
knizocytes and echinocytes. However, there were significant
differences between the negative impact of the studied
graphene forms, indicating that hydrophobic, reduced
graphene nanoparticles (GN and rGO) are more toxic than
those of the hydrophilic, oxidized form (GO). Moreover, GN
produced by physical method of exfoliation had a higher
hemolytic activity compared to chemically produced rGO.
Our findings showed that different forms of graphene, de-
pending on methods of production and surface modification,
have a different hemocompatibility. Thus, these factors
should be carefully studied and considered before medical
application.
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Fig. 6 Level of hemolysis of red blood cells. Error bars indicate standard
error of the mean. Bars with different superscripts denote statistically
significant differences between the control group (non-treated) and
groups treated with the following: pristine graphene, oxidized graphene,
reduced oxidized graphene, and 3% hydrogen peroxide-positive control
(P < 0.05). There were significant differences (P < 0.05) between
different concentrations of graphenes
Fig. 7 Effect of pristine graphene (GN), oxidized graphene (GO), and
reduced oxidized graphene (rGO) on the ROS production of red blood
cells. Bars with different superscripts denote statistically significant
differences between the control group (non-treated) and groups treated
with the following: GN, GO, rGO, and 3% hydrogen peroxide-positive
control (P < 0.05). There were significant differences (P < 0.05) between
different concentrations of graphenes
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